DISEASE CANCELLING
DEAD

Serial Number

88718603

Owner

Immuneering Corporation

Attorney

Ian W. Gillies

Filing Date

Dec 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

DISEASE CANCELLING Trademark

Serial Number: 88718603

DISEASE CANCELLING is a trademark filed by Immuneering Corporation on December 6, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Immuneering Corporation (7 trademarks)

Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

December 6, 2019

Registration Date

Not Registered

Published for Opposition

November 10, 2020

Goods & Services

chemical preparations and reagents for pharmaceutical, medical, and medical clinical purposes, namely, for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders; pharmaceuticals, pharmaceutical preparations and substances developed with a computer software platform using biology and chemistry analytics for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders; pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 7, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 7, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2022 EXRA
SOU EXTENSION 4 GRANTED
Dec 16, 2022 EX4G
SOU EXTENSION 4 FILED
Dec 16, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 16, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jun 17, 2022 EX3G
SOU EXTENSION 3 FILED
Jun 17, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 17, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2021 EXRA
SOU EXTENSION 2 GRANTED
Dec 15, 2021 EX2G
SOU EXTENSION 2 FILED
Dec 15, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 15, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2021 EXRA
CORRECTED NOA E-MAILED
Jul 8, 2021 NOAC
SOU EXTENSION 1 GRANTED
Jul 7, 2021 EX1G
DIVISIONAL PROCESSING COMPLETE
Jul 7, 2021 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 2, 2021 AITU
SOU EXTENSION 1 FILED
Jun 24, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 24, 2021 EEXT
DIVISIONAL REQUEST RECEIVED
Jun 23, 2021 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 23, 2021 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 5, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 11, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 11, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2019 NWOS
NEW APPLICATION ENTERED
Dec 10, 2019 NWAP